In a report released today, Nicholas Yulico from Scotiabank maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report), with a price target of $14.00. The company’s shares closed yesterday at $14.22.
Yulico covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, AvalonBay, and Boston Properties. According to TipRanks, Yulico has an average return of 0.4% and a 48.04% success rate on recommended stocks.
In addition to Scotiabank, Sabra Healthcare REIT also received a Hold from JMP Securities’s Aaron Hecht in a report issued today. However, on November 7, Mizuho Securities reiterated a Buy rating on Sabra Healthcare REIT (NASDAQ: SBRA).
See today’s best-performing stocks on TipRanks >>
Based on Sabra Healthcare REIT’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $161.63 million and a GAAP net loss of $15.1 million. In comparison, last year the company earned a revenue of $155.96 million and had a net profit of $16.81 million
Based on the recent corporate insider activity of 61 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SBRA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sabra Healthcare REIT (SBRA) Company Description:
Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing, and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Read More on SBRA:
- Sabra Health Care reports Q3 FFO 33c, consensus 34c
- Sabra Healthcare Reit (SBRA) Q3 Earnings Cheat Sheet
- Sabra Health Care added to ‘Endeavor List’ at BofA
- Sabra Health Care downgraded to Market Perform from Outperform at BMO Capital
- Sabra Health Care upgraded to Equal Weight from Underweight at Wells Fargo
